The International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine (IFAPP) Academy is a non-profit organization based in the USA, affiliated with IFAPP, and is comprised of a unique partnership between academia, industry, and professional associations to foster competencies and improving performance in medical affairs and medicines development. The IFAPP-Kings College Medical Affairs in Medicines Development Certification Program was created to achieve this goal.
The aim of the e-learning course is to provide the core cognitive competencies for an effective performance in medicines development and medical affairs. The certification program is of particular value for those individuals already working in (or interested in joining) pharmaceuticals, academia, and regulatory agencies.
Students successfully completing the course will receive a Certificate granted by King’s College London and IFAPP Academy and a Professional Certification granted by IFAPP and the IFAPP Academy. The use of post-nominal letters (CMD) to attest certification will be awarded.
PROGRAM SUMMARY |
|---|
|
Value of
Certification
Patients, physicians, health care providers, insurers and quality organizations regard certification as an important measure of a biomedical professional’s knowledge, experience and skills to provide quality health care services within a given specialty.
Value of
Medical Affairs
The pharmaceutical industry has seen major changes over the past decade. As market pressure has intensified and commercial practices have come under closer scrutiny, there has been a marked increase in scientific rigor across the industry. One consequence of this shift has been a renewed emphasis on the importance of the Medical Affairs function.
Strategic Alliance
King’s College London
On September 1st, 2016 IFAPP and King’s College London agreed to establish a strategic collaboration for the production and delivery of a Professional Certification Program in Medical Affairs in Medicines Development with the involvement of the IFAPP Academy.
Hot Topics of
Medical Affairs
News from
IFAPP Academy
Academic Partner
Founding Sponsors
COVID-19 Vaccine Development and Testing at a Record-Setting Rate
/in Hot Topics in Medical Affairs /by Amanda SchmittCOVID-19 Vaccine – May 5th, 2020 at 6:45 AM EDT, Pfizer Inc. and BioNTech SE announced that the first participants have been dosed in the U.S. in the Phase 1/2 clinical trial for the BNT162 vaccine program to prevent COVID-19. The trial is part of a global development program, and the dosing of the first cohort in Germany was completed last week.